Clinical Edge Journal Scan

High physical activity reduces visceral fat mass and percentage body fat in PsA


 

Key clinical point: The visceral fat mass and percentage body fat were significantly higher in patients with psoriatic arthritis (PsA) compared with control individuals, and moderate-to-high physical activity was associated with reduced visceral fat mass and percentage body fat.

Major finding: PsA was associated with a mean increase in visceral fat mass of 2.0 kg (95% CI 1.2-2.8 kg) and in percentage body fat of 2.7% (95% CI 1.6%-3.8%). Moderate and high vs low physical activity were associated with lower visceral fat mass and percentage body fat in patients with PsA and control individuals (P < .001).

Study details: The data come from a retrospective study including 356 patients with PsA and 47,470 control individuals.

Disclosures: This study was funded by the Faculty of Medicine and Health Sciences at Norwegian University of Science and Technology. M Hoff declared receiving speaker honoraria from AbbVie and Janssen Pharmaceuticals. No other conflicts of interest were declared.

Source: Osman AA et al. High physical activity in persons with psoriatic arthritis is associated with reduced visceral fat mass and percentage body fat: The Trøndelag Health study. Rheumatol Int. 2023 (Jun 5). doi: 10.1007/s00296-023-05348-9

Recommended Reading

High-intensity interval training has sustainable effects in patients with inflammatory arthritis
MDedge Rheumatology
Brepocitinib shows promise in phase 2 trial for psoriatic arthritis
MDedge Rheumatology
Study supports position of methotrexate in treatment algorithm for PsA
MDedge Rheumatology
Etanercept safe and effective in juvenile psoriatic arthritis
MDedge Rheumatology
Axial spondyloarthritis and PsA with axial involvement are distinct entities
MDedge Rheumatology
Apremilast significantly improves dactylitis and enthesitis in PsA
MDedge Rheumatology
No clinically meaningful difference in response to ustekinumab in younger vs older patients with PsA
MDedge Rheumatology
Serum interleukin-36 alpha: A potential biomarker to differentiate PsA from Behçet’s syndrome
MDedge Rheumatology
Patients with PsA, especially women, likely to have abnormal sleep behavior
MDedge Rheumatology
Higher disease burden among women with PsA vs RA
MDedge Rheumatology